PRP vs hyaluronic acid injections: a plain comparison

Hyaluronic acid has a longer FDA track record, while PRP has performed better in recent trials beyond the first few months. We hear this question most often from readers who have already tried physical therapy and are deciding which injection to consider next. Both are used mainly for knee osteoarthritis, but neither can reverse the underlying joint damage. In practice, the key differences come down to cost, regulatory status, trial evidence, and safety.

PRP vs Hyaluronic Acid at a Glance

The table covers the criteria that separate PRP from hyaluronic acid for most readers.

The pattern: hyaluronic acid carries the formal FDA clearance and the better insurance odds. PRP costs more out of pocket, but the more recent trial data shows it pulling ahead on pain and function scores by the one-year mark.

What Each Injection Is

PRP and hyaluronic acid work through entirely different mechanisms, which is easy to lose track of since both get injected into the same joint.

PRP is platelet-rich plasma. A provider draws your blood, spins it in a centrifuge to concentrate the platelets, then injects that concentrate into the joint. The platelets release growth factors, signaling proteins tied to your body’s healing response.

Hyaluronic acid, sometimes called viscosupplementation, is different in kind. It’s a naturally occurring substance already present in healthy joint fluid, and the injected version is either lab-made or derived from rooster combs. Rather than signaling anything, it adds lubrication and cushioning directly, more like topping off the joint’s own oil than triggering a biological response.

Only Hyaluronic Acid Has an FDA Clearance

Hyaluronic acid has something PRP doesn’t: an actual FDA clearance for this specific use. Products like Synvisc and Euflexxa have been FDA-cleared as medical devices for knee osteoarthritis pain since 1997, indicated for patients who haven’t responded adequately to simpler options like acetaminophen or physical therapy.

PRP carries no such clearance. The U.S. Food and Drug Administration has not approved any PRP product for joint use, which is why PRP remains an off-label application of a blood-processing kit rather than a cleared knee-osteoarthritis treatment in its own right.

That gap matters beyond paperwork. It’s part of why hyaluronic acid gets covered by insurance and Medicare in specific circumstances, while PRP almost never does, regardless of how the trial data compares.

Hyaluronic Acid Usually Costs Less

Hyaluronic acid is the cheaper option in most cases. A full course, typically three to five weekly injections, runs $300 to $1,500, and Medicare and many private plans cover it for documented knee osteoarthritis that hasn’t responded to cheaper treatments.

A PRP course costs more and is rarely covered. Budget $500 to $2,500 for one to three sessions, nearly all of it out of pocket. Our PRP injection cost guide breaks the price down further by body area.

Do the math for a repeat scenario before choosing. Hyaluronic acid is often re-injected every six months, so two courses in a year at $800 each runs $1,600. A single PRP course at $1,500 that holds for a full year lands close to the same total. The trial data on duration changes that comparison, and it affects your wallet directly, beyond just the pain scores.

What the Trial Data Shows

The clearest picture comes from a meta-analysis of 14 randomized controlled trials covering 1,512 patients, split roughly evenly between the two injections. At one month, pain scores showed no measurable difference between PRP and hyaluronic acid.

The gap opened after that. By three months, PRP showed a modest edge on pain scores. By 12 months, that edge widened further, and function scores measured by the WOMAC index favored PRP at every checkpoint the review tracked, from one month through twelve. The same review noted more injection-site pain in the PRP group, though no severe complications turned up in either arm.

A separate 2026 meta-analysis of PRP trials reached a similar conclusion for knee osteoarthritis broadly. It found PRP often outperformed both hyaluronic acid and placebo for pain. But it flagged a real caveat: results shifted with how each clinic prepared the PRP. That matters here. A hyaluronic acid product ships in a standardized, FDA-cleared formulation. PRP does not. It varies by the centrifuge, the spin protocol, and the platelet concentration a given clinic delivers.

Both Injections Are Generally Mild

Neither injection carries serious documented risk in these trials. Each has its own common complaint, though. PRP’s main downside is injection-site soreness, sometimes worse than a standard shot because of the higher platelet concentration. Hyaluronic acid’s most common issue is a temporary flare of joint swelling in the day or two after injection, occasionally severe enough that a provider drains the joint.

Hyaluronic acid is a standardized, FDA-cleared product, so what you get is predictable batch to batch. PRP is not standardized. It’s prepared fresh from your own blood at each visit, so quality depends heavily on the specific clinic’s equipment and protocol. That variability is real, and no amount of research settles it before you sit in the clinic’s chair.

Who This Is Not For

Hyaluronic acid is a weak fit for a joint that’s already bone-on-bone. The lubrication it adds has less cartilage surface left to protect, and clinics often report diminishing returns at that stage. It’s also not for anyone with a known allergy to hyaluronan-based or avian-derived products, since some formulations are rooster-comb derived.

PRP is a poor fit if you’re on a blood thinner or have an active infection near the injection site. Skip it, too, if a real insurance-covered option is available and affordable. Hyaluronic acid’s coverage odds are meaningfully better for the same joint.

What Would Change This Answer

A hyaluronic acid product’s cost dropping under a generous insurance plan, or a broader FDA clearance for PRP specifically, would tilt the practical case back toward hyaluronic acid even if PRP’s evidence stayed the same. On the other side, a large trial standardizing PRP preparation and still showing its 12-month advantage would remove the biggest caveat against it, the prep-method variability the 2026 meta-analysis flagged. Neither has happened yet.

A Simple Way to Decide

Match the injection to your insurance situation and your joint’s actual condition. Do not match it to whichever one a clinic mentions first.

1. Insurance covers hyaluronic acid for your case? That coverage gap alone often settles the decision, since PRP rarely gets the same treatment from a payer.
2. Joint is already bone-on-bone on imaging? Both injections tend to underperform at that stage, and a surgical consult is usually the more useful next conversation.
3. Paying out of pocket either way? The 12-month trial data gives PRP a real edge, which narrows the cost gap once you count a likely hyaluronic acid repeat course.
4. Clinic can’t say how it prepares its PRP? That’s worth asking directly, since the evidence itself flags preparation method as a source of inconsistent results.
5. Still unsure? Ask your provider for your joint’s actual cartilage status before either injection, since that detail changes the odds for both options more than the marketing for either one does.

A Common Mistake with Hyaluronic Acid Specifically

The failure mode we see most often with hyaluronic acid is treating it as a routine refill rather than reassessing the joint. A patient gets real relief from a first course, books a repeat every six months for two or three years, and never has new imaging taken in between. Meanwhile the underlying arthritis has kept progressing, and by the third or fourth course, the joint has crossed into bone-on-bone territory where hyaluronic acid’s lubrication effect has far less cartilage surface left to help.

The fix is straightforward. Treat a repeat hyaluronic acid course as a checkpoint. It is not an automatic subscription. Ask for updated imaging every year or two, and if the relief from each successive course gets shorter or weaker, that’s the signal to ask whether the joint has progressed past where an injection alone can help, rather than simply booking the next round on schedule.

The Bottom Line on PRP vs Hyaluronic Acid

Hyaluronic acid carries the real FDA clearance and the better insurance odds for knee osteoarthritis. PRP costs more and lacks any FDA approval for joint use, but the more recent trial data shows it edging ahead on pain and function by the 12-month mark. Neither is proven to reverse the arthritis causing your pain. Price both options with the cost estimator, ask your provider whether your specific joint still has enough cartilage left for hyaluronic acid to help, and choose based on your actual insurance situation and timeline rather than which injection a clinic pushes harder.